top
Search terms
Results 1 - 10 of 22 - ordered by :
Pages: 1 2 3
Escardio

Early use of an implantable cardioverter-defibrillator (ICD) after primary coronary intervention lengthens survival in patients at high risk of death after ST-segment elevation myocardial infarction ...

Date : 03/09/2019
Escardio

Genotype-guided oral P2Y12 inhibition reduces bleeding without raising clotting risk in heart attack patients undergoing stent implantation, according to late breaking results from the POPular ...

Date : 03/09/2019
Escardio

“How to best manage the non-culprit lesions in patients with ST-elevation myocardial infarction (STEMI) and multivessel coronary artery disease has been a dilemma for some time,” explains ...

Date : 02/09/2019
Escardio

According to current clinical practice guidelines, prasugrel and ticagrelor have equal, Class I recommendations for use following percutaneous coronary intervention (PCI) in acute coronary syndromes ...

Date : 02/09/2019
Escardio

Up to 50% of patients with ST-segment elevation myocardial infarction (STEMI) have multivessel coronary artery disease. Prior randomised trials found declines in composite outcomes with non-culprit ...

Date : 01/09/2019
Escardio

First randomised trial tests criteria used to diagnose heart attack The Universal Definition of Myocardial Infarction recommends that any increase in troponin above the 99th centile of a healthy ...

Date : 28/08/2018
Escardio

Clinical outcome in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) has progressively improved within the last two decades, in part because of faster diagnosis with invasive ...

Date : 28/08/2018
Escardio

The foods that make up a heart healthy diet for people worldwide may differ from what was previously thought, according to late breaking results from the observational Prospective Urban Rural ...

Date : 28/08/2018
Escardio

Prof. Zannad points out that, “Rivaroxaban is approved at higher doses to treat conditions such as atrial fibrillation (AF) and venous thromboembolism, but in COMMANDER HF, patients were ...

Date : 28/08/2018
Escardio

Long-term antiplatelet monotherapy after stenting is safe but does not reduce the risk of death or heart attack compared to standard dual antiplatelet therapy, according to late breaking results from ...

Date : 27/08/2018